Home/All Molecules/Rosuvastatin

Rosuvastatin Range

Comprehensive Rosuvastatin portfolio for Franchise & Manufacturing.

Category
rosuvastatin
Total Formulations
20
Available Forms
Capsule, Tablets

Expand Your Business with Our Multiple Divisions


Browse Rosuvastatin portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Rosuvastatin batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Rosuvastatin PCD Pharma Franchise

Rosuvastatin PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Rosuvastatin PCD pharma franchise company offering a portfolio of 20 Rosuvastatin formulations across tablets and capsules. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Rosuvastatin?

Rosuvastatin is a HMG-CoA reductase inhibitor (statin). It blocks the rate-limiting enzyme of hepatic cholesterol synthesis, upregulating LDL receptors and lowering circulating LDL cholesterol, with modest triglyceride reduction and a small rise in HDL. The compound record can be reviewed on PubChem.

Therapeutic Applications

Primary hypercholesterolaemia and mixed dyslipidaemia, familial hypercholesterolaemia, and primary and secondary prevention of atherosclerotic cardiovascular events. It is frequently combined with fenofibrate, ezetimibe, aspirin or clopidogrel in fixed-dose cardiology packs.

Prescribed by: Cardiologists, diabetologists, endocrinologists and general physicians prescribe Rosuvastatin; it is also initiated by nephrologists in patients with high cardiovascular risk.

Why Rosuvastatin is a High-Potential Molecule for Distributors

Statins are among the most chronic prescriptions in medicine: once initiated for cardiovascular prevention, therapy typically continues for life, so each new patient represents years of monthly refills. Rosuvastatin is the most potent statin per milligram, which has made it the default choice for high-risk patients and a fast-growing share of the Indian dyslipidaemia market against atorvastatin. With 20 formulations including combination packs, a distributor can supply cardiology, diabetology and general-physician demand from one molecule and anchor an entire cardio-diabetic range around it.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Rosuvastatin franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Rosuvastatin business in your region.

References

  1. PubChem – Rosuvastatin compound record, US National Library of Medicine
  2. PubMed – clinical literature on Rosuvastatin, NCBI

Aceclofenac in Modern Clinical Practice

Our formulations of Rosuvastatin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Rosuvastatin in PCD Franchise

Start Your Rosuvastatin Franchise with Cafoli Lifecare

Ready to take monopoly rights for Rosuvastatin in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 20 Rosuvastatin formulations in tablets and capsules. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Rosuvastatin range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

Cardiologists, diabetologists, endocrinologists and general physicians prescribe Rosuvastatin; it is also initiated by nephrologists in patients with high cardiovascular risk.

Rosuvastatin gives greater LDL reduction at lower milligram doses and has a longer half-life, so cardiologists reach for it in high-risk and difficult-to-control dyslipidaemia. That potency advantage, combined with a wide combination-pack range with fenofibrate, ezetimibe and antiplatelets, is why the molecule has been taking share and why it carries strong repeat demand for distributors.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Rosuvastatin franchise agreement and monopoly allotment can be processed.